Repare Therapeutics【RPTX】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.145

買値

1.10

売値

1.19

出来高

334,543

1.10 日の範囲 1.16

1.11 52 週間の範囲 8.49

時価総額

48.675M

前日終値

1.15

始値

1.15

時刻

1.1495

最終取引時間

06:21:32

財務取引量

US$ 377,193

VWAP

1.1275

平均取引量 (3 か月)

479,425

発行済株式数

42,510,708

配当利回り

PER

-0.52

1 株当たり利益 (EPS)

-2.21

歳入

51.13M

純利益

-93.8M

Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.reparerx.com

本社

Saint-laurent, Quebec, Can

設立

Repare Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker RPTX. The last closing price for Repare Therapeutics was US$1.15. Over the last year, Repare Therapeutics shares have traded in a share price range of US$ 1.11 to US$ 8.49.

Repare Therapeutics currently has 42,510,708 shares in issue. The market capitalisation of Repare Therapeutics is US$48.89 million. Repare Therapeutics has a price to earnings ratio (PE ratio) of -0.52.

Form 8-K - Current report

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions

Realigning resources to extend runway to mid-2027 Focus on clinical development of RP-1664 (PLK4 inhibitor) and RP-3467 (Polθ ATPase inhibitor), with initial clinical readouts expected beginning...

Form 8-K - Current report

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial

Heavily-pretreated patients on lunresertib and camonsertib combination achieved 25.9% overall response rate (ORR) in endometrial cancer and 37.5% in platinum-resistant ovarian cancer Nearly half...

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial

Event to be webcast live on Thursday, December 12 at 4:30 p.m. ET Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.085	-6.91056910569	1.23	1.27	1.11	337257	1.17628757	CS
4	-0.1708	-12.9806961544	1.3158	1.48	1.11	447726	1.30386443	CS
12	-2.845	-71.3032581454	3.99	4.0695	1.11	479425	1.92742688	CS
26	-2.875	-71.5174129353	4.02	4.22	1.11	263864	2.22585862	CS
52	-5.395	-82.4923547401	6.54	8.49	1.11	228318	3.13647136	CS
156	-13.315	-92.081604426	14.46	18.68	1.11	250356	8.7427592	CS
260	-30.905	-96.4274570983	32.05	46.44	1.11	217014	13.74504084	CS

RPTX - Frequently Asked Questions (FAQ)

What is the current Repare Therapeutics share price?

The current share price of Repare Therapeutics is US$ 1.145

How many Repare Therapeutics shares are in issue?

Repare Therapeutics has 42,510,708 shares in issue

What is the market cap of Repare Therapeutics?

The market capitalisation of Repare Therapeutics is USD 48.89M

What is the 1 year trading range for Repare Therapeutics share price?

Repare Therapeutics has traded in the range of US$ 1.11 to US$ 8.49 during the past year

What is the PE ratio of Repare Therapeutics?

The price to earnings ratio of Repare Therapeutics is -0.52

What is the cash to sales ratio of Repare Therapeutics?

The cash to sales ratio of Repare Therapeutics is 0.95

What is the reporting currency for Repare Therapeutics?

Repare Therapeutics reports financial results in USD

What is the latest annual turnover for Repare Therapeutics?

The latest annual turnover of Repare Therapeutics is USD 51.13M

What is the latest annual profit for Repare Therapeutics?

The latest annual profit of Repare Therapeutics is USD -93.8M

What is the registered address of Repare Therapeutics?

The registered address for Repare Therapeutics is 7210 FREDERICK-BANTING STREET, SUITE 100, SAINT-LAURENT, QUEBEC, H4S 2A1

What is the Repare Therapeutics website address?

The website address for Repare Therapeutics is www.reparerx.com

Which industry sector does Repare Therapeutics operate in?

Repare Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
PCSAProcessa Pharmaceuticals Inc	US$ 0.7413 (25.16%)	1.59M
HUBCWHub Cyber Security Ltd	US$ 0.037 (23.33%)	100
CARMCarisma Therapeutics Inc	US$ 0.60 (18.88%)	4.14M
OSTOstin Technology Group Company Ltd	US$ 3.48 (18.77%)	2.57M
FBLGFibroBiologics Inc	US$ 1.7888 (14.67%)	2.12k
CRGXCARGO Therapeutics Inc	US$ 3.73 (-71.72%)	1.58M
FIBKFirst Interstate BancSystem Inc	US$ 27.25 (-17.07%)	8.59k
IRWDIronwood Pharmaceuticals Inc	US$ 3.11 (-16.40%)	29.65k
DXSTDecent Holding Inc	US$ 1.9288 (-10.62%)	263.7k
MXLMaxLinear Inc	US$ 19.50 (-10.51%)	88.63k
NVDANVIDIA Corporation	US$ 125.7899 (1.69%)	30.88M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 26.4987 (7.15%)	16.82M
TSLATesla Inc	US$ 402.99 (3.57%)	11.95M
PLUGPlug Power Inc	US$ 1.88 (0.00%)	9.77M
VCSHVanguard Short Term Corporate Bond	US$ 78.41 (0.00%)	9.57M